Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of $117.03B. The enterprise value is $153.96B.

Bristol-Myers Squibb has 2,042,071,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bristol-Myers Squibb’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 13.90%.

The current PE Ratio of Bristol-Myers Squibb is 11.6. Bristol-Myers Squibb’s PEG ratio is -0.09.

In the last 12 months, Bristol-Myers Squibb had revenue of 48.19B and earned 7.05B in profits. Earnings per share was 3.46.

In the last 12 months, operating cash flow was 13.31B and capital expenditures -1.40B, giving a free cash flow of 11.91B billion.

Bristol-Myers Squibb pays an annual dividend of $0.63, resulting in a dividend yield of 4.11%

Bristol-Myers Squibb upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).

Bristol-Myers Squibb as a current ratio of 1.26, with Debt / Equity ratio of 221.55%

In the past 12 months, Bristol-Myers Squibb has paid 2.27B in taxes.

Bristol-Myers Squibb EV to EBITDA ratio is 10.11, with an EV/FCF ratio of 11.45.

Bristol-Myers Squibb has $10.49B in cash and marketable securities with $44.46B in debt, giving a net cash position of -$33.97B billion.

Gross margin is 68.75%, with operating margin of 26.34%, and net profit margin of 14.63%.

The average price target for Bristol-Myers Squibb is $64.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy